Dabigatran Etexilate Shortage Update: What Patients Need to Know in 2026

Dabigatran Etexilate in 2026: Is There a Shortage?

If you take Dabigatran Etexilate (brand name Pradaxa) to prevent stroke or treat blood clots, you may have heard reports about drug shortages affecting many common medications. Naturally, you want to know: is Dabigatran Etexilate one of them?

Here's what we know as of early 2026, along with practical steps you can take to protect your health.

Is Dabigatran Etexilate Still in Shortage?

As of early 2026, Dabigatran Etexilate is not on the FDA's official drug shortage list. The entry of multiple generic manufacturers into the market following Pradaxa's patent expiration has helped stabilize the supply of this medication.

That said, you may still encounter difficulties finding Dabigatran Etexilate at your local pharmacy. This doesn't necessarily mean there's a national shortage — it may reflect local supply chain issues, low demand at your particular pharmacy, or temporary distributor disruptions.

Why Is Dabigatran Etexilate Hard to Find?

Even without a formal shortage, several factors can make it difficult to pick up your prescription:

Pharmacy Stocking Patterns

Not every pharmacy stocks every strength of Dabigatran Etexilate. The 150 mg capsule is the most commonly prescribed, but the 75 mg and 110 mg strengths may not be kept in stock at all pharmacies. If your doctor prescribes a less common strength, you may need to call around or have your pharmacy order it.

Generic Manufacturer Variability

Multiple manufacturers now produce generic Dabigatran Etexilate Mesylate capsules. While this generally improves availability, it can also create complexity. Your pharmacy's distributor may carry one manufacturer's product but not another, leading to occasional gaps. For more details, see our article on why Dabigatran Etexilate can be hard to find.

Broader Supply Chain Pressures

The pharmaceutical supply chain continues to face challenges in 2026. Raw material sourcing, manufacturing capacity, and distribution logistics can all contribute to temporary stockouts — even for medications that aren't in an official shortage.

What Does Dabigatran Etexilate Cost in 2026?

Cost is a major factor in whether patients can access their medication. Here's what you can expect to pay:

• Brand Pradaxa: Approximately $481 for 60 capsules (150 mg) at retail price without insurance
• Generic Dabigatran (retail): Approximately $215 to $386 for 60 capsules (150 mg) without insurance
• Generic Dabigatran (with coupon): As low as $47 to $55 for 60 capsules (150 mg) using free discount coupons from GoodRx or SingleCare
• With insurance: Typical copay of $10 to $50 per month for generic Dabigatran on most commercial and Medicare Part D plans

The availability of generic Dabigatran has dramatically reduced the cost compared to when Pradaxa was brand-only. If cost is a concern, our guide on saving money on Dabigatran Etexilate covers all your options in detail.

Are There New Options in 2026?

The anticoagulant landscape continues to evolve:

• Generic competition: Multiple generic Dabigatran manufacturers now compete, keeping prices low
• Generic Apixaban (Eliquis): Generic versions of this popular alternative DOAC are now available, giving patients more affordable choices
• Discount programs: Free prescription discount cards from services like GoodRx, SingleCare, and RxSaver can reduce the cost of generic Dabigatran to under $55 per month
• Patient assistance: The Boehringer Ingelheim CARES Foundation continues to offer free brand Pradaxa to qualifying uninsured patients

If Dabigatran Etexilate isn't the right fit for you — whether due to side effects, cost, or availability — there are several alternatives worth discussing with your doctor.

How to Find Dabigatran Etexilate in Stock

If you're having trouble locating your medication, here's what to do:

1. Search on Medfinder: Use Medfinder to check which pharmacies near you have Dabigatran Etexilate available right now
2. Call independent pharmacies: They often have more flexibility with suppliers than big chains
3. Ask for a special order: Most pharmacies can get Dabigatran Etexilate within 1-2 business days from their distributor
4. Consider mail-order: Your insurance plan may offer a 90-day mail-order option at a lower copay
5. Contact your doctor: If you're about to run out, your doctor may be able to prescribe a temporary bridge or call in the script to a pharmacy that has it

For a complete walkthrough, read our guide on how to find Dabigatran Etexilate in stock near you.

Final Thoughts

The Dabigatran Etexilate supply picture in 2026 is generally stable, thanks to multiple generic manufacturers keeping the market well-supplied. While you may occasionally hit a snag at your local pharmacy, a national shortage is unlikely.

The most important thing is to plan ahead and never let yourself run completely out of this medication. Dabigatran Etexilate carries a boxed warning about the risks of premature discontinuation — stopping suddenly can increase your risk of stroke and blood clots. Stay proactive, use tools like Medfinder, and keep your doctor in the loop if you're having any trouble with access.